Anthony A.. Florence Jr's Net Worth

$331 Thousand

Estimate Recalculated Jun 18, 2025 08:31PM EST

Who is Anthony A.. Florence Jr

Anthony A.. Florence Jr does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arcellx, Inc., Berkshire Grey, Inc., Oyster Point Pharma, Inc., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Galera Therapeutics, Inc., IMARA Inc., ZeroFox Holdings, Inc., Senti Biosciences, Inc.\, Mersana Therapeutics, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Desktop Metal, Inc., Cascadian Therapeutics, Inc., MULESOFT, INC, Robinhood Markets, Inc., Nkarta, Inc., NeueHealth, Inc., Verona Pharma plc, Monte Rosa Therapeutics, Inc., AVEO PHARMACEUTICALS INC, APPIAN CORP, Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, Loxo Oncology, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., ARDELYX, INC., Savara Inc, Trevi Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Annexon, Inc., Mirna Therapeutics, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Cerecor Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., Marker Therapeutics, Inc., Casper Sleep Inc., Strongbridge Biopharma plc, CVENT INC, Achaogen Inc, Care.com Inc, INTERLEUKIN GENETICS INC, and Korro Bio, Inc..

SEC CIK

Anthony A.. Florence Jr's CIK is 0001559827

Past Insider Trading and Trends

2014 was Anthony A.. Florence Jr's most active year for acquiring shares with 4 total transactions. Anthony A.. Florence Jr's most active month to acquire stocks was the month of May. 2015 was Anthony A.. Florence Jr's most active year for disposing of shares, totalling 2 transactions. Anthony A.. Florence Jr's most active month to dispose stocks was the month of December. 2014 saw Anthony A.. Florence Jr paying a total of $3,120.59 for 507 shares, this is the most they've acquired in one year. In 2022 Anthony A.. Florence Jr cashed out on 33,394 shares for a total of $230,418.60, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Berkshire Grey, Inc.

Investor
Updated Jul 24, 2023
Form 4
-100.00%
-38.18M
Jul 24, 2023
Disposition
Jul 20
Form 3
Jul 30, 2021
38.18M
Showing 2 results

Nightstar Therapeutics plc

Investor
Updated Jun 07, 2019
Form 4
-100.00%
-6.66M
$25.50
-$169.89M
Jun 07, 2019
Disposition
Jun 07
Form 3
Jan 02, 2019
6.66M
Showing 2 results

Reneo Pharmaceuticals, Inc.

Investor
Updated Apr 15, 2021
Form 4
-74.04%
-13.65M
$15.00
Apr 15, 2021
4.79M
Buy-Options
Apr 13
Form 3
Apr 08, 2021
Showing 2 results

Arcellx, Inc.

Investor
Updated Dec 22, 2022
Form 4
-29.65%
-2.00M
$30.74
$5.50K
Dec 22, 2022
4.75M
Sale
Dec 20 - Dec 21
Form 4
4.86%
312.50K
$16.00
$5.00M
Jun 23, 2022
6.75M
Purchase
Jun 21
Form 4
32.65%
1.58M
$15.00
$23.75M
Feb 09, 2022
6.43M
Purchase
Feb 08
Form 3
Feb 03, 2022
Showing 4 results

Oyster Point Pharma, Inc.

Investor
Updated Nov 04, 2019
Form 4
18.74%
935.00K
$16.00
Nov 04, 2019
5.93M
Purchase
Nov 04
Form 3
Oct 30, 2019
322.46K
Showing 2 results

IonQ, Inc.

Investor
Updated Nov 18, 2022
Form 4
-44.44%
-11.69M
Nov 18, 2022
14.62M
Disposition
Nov 16
Form 4
-10.00%
-2.92M
$5.84
-$17.07M
May 31, 2022
26.31M
Sale
May 26 - May 31
Form 3
Oct 04, 2021
29.23M
Showing 3 results

Galera Therapeutics, Inc.

Investor
Updated Nov 12, 2019
Form 4
-78.13%
-15.57M
$12.00
Nov 12, 2019
4.36M
Buy-Options
Nov 12
Form 3
Nov 06, 2019
Showing 2 results

IMARA Inc.

Investor
Updated Apr 07, 2022
Form 4
-21.01%
-694.55K
$1.08
-$751.26K
Apr 07, 2022
2.61M
Sale
Apr 05 - Apr 06
Form 4
-3.91%
-134.56K
$1.50
-$202.21K
Jan 25, 2022
3.31M
Sale
Jan 21 - Jan 25
Form 4
-0.77%
-26.55K
$1.83
-$48.73K
Jan 20, 2022
3.44M
Sale
Jan 18 - Jan 20
Form 4
-0.62%
-21.55K
$1.94
-$41.83K
Jan 14, 2022
3.47M
Sale
Jan 12 - Jan 14
Form 4
-0.53%
-18.76K
$2.07
-$38.74K
Jan 11, 2022
3.49M
Sale
Jan 07 - Jan 11
Form 4
-0.90%
-31.92K
$2.26
-$72.19K
Jan 06, 2022
3.51M
Sale
Jan 04 - Jan 06
Form 4
-3.19%
-116.48K
$2.29
-$266.87K
Jan 03, 2022
3.54M
Sale
Dec 30 - Jan 03
Form 4
-1.81%
-67.43K
$2.37
-$159.50K
Dec 29, 2021
3.66M
Sale
Dec 27 - Dec 29
Form 4
-7.25%
-291.15K
$2.36
-$688.50K
Dec 27, 2021
3.72M
Sale
Dec 09 - Dec 23
Form 4
-81.99%
-18.28M
$16.00
Mar 16, 2020
4.01M
Buy-Options
Mar 16
Form 3
Mar 11, 2020
Showing 11 results

ZeroFox Holdings, Inc.

Investor
Updated May 15, 2024
Form 4
-100.00%
-18.07M
May 15, 2024
Disposition
May 13
Form 3
Aug 05, 2022
18.07M
Showing 2 results

Senti Biosciences, Inc.\

Investor
Updated Jun 15, 2022
Form 3
Jun 15, 2022
4.43M
Showing 1 results

SYNLOGIC, INC.

Investor
Updated Oct 06, 2023
Form 3
Oct 06, 2023
2.92M
Form 4
10.74%
410.00K
$9.75
$4.00M
Jan 26, 2018
4.23M
Grant
Jan 26
Form 4
799.63%
3.39M
Aug 30, 2017
3.82M
Grant
Aug 28
Form 4
62.80%
1.15M
$7.00
Oct 06, 2015
2.97M
Purchase
Oct 05 - Oct 06
Form 3
Sep 30, 2015
Showing 5 results

Mersana Therapeutics, Inc.

Investor
Updated Sep 16, 2020
Form 4
-24.98%
-1.99M
Sep 16, 2020
5.97M
Disposition
Sep 14
Form 4
-33.43%
-4.00M
$8.50
-$177.78K
Apr 13, 2020
7.96M
Sale
Apr 09 - Apr 13
Form 4
-0.01%
-1.21K
$1.48
$5.64
Apr 13, 2020
11.96M
Sale
Aug 28
Form 4
46.07%
3.75M
$4.00
$15.00M
Mar 06, 2019
11.89M
Purchase
Mar 05
Form 4
-74.68%
-24.01M
$15.00
Jul 06, 2017
8.14M
Buy-Options
Jul 03
Form 3
Jun 27, 2017
Showing 6 results

CHAMPIONS ONCOLOGY, INC.

Investor
Updated Mar 10, 2020
Form 4
-29.24%
-708.15K
$6.38
-$3.45
Mar 10, 2020
1.71M
Sale
Mar 06
Form 3
Mar 24, 2015
18.75M
Showing 2 results

Surface Oncology, Inc.

Investor
Updated May 22, 2020
Form 4
-12.68%
-420.00K
$3.66
-$1.54M
May 22, 2020
2.89M
Sale
May 20
Form 4
-52.64%
-3.68M
$15.00
Apr 23, 2018
3.31M
Buy-Options
Apr 23
Form 3
Apr 18, 2018
Showing 3 results

Desktop Metal, Inc.

Investor
Updated Jun 10, 2021
Form 4
-31.84%
-9.00M
Jun 10, 2021
19.26M
Disposition
Jun 08
Form 3
Dec 11, 2020
28.40M
Showing 2 results

Cascadian Therapeutics, Inc.

Investor
Updated Mar 13, 2018
Form 4
-100.00%
-10.88M
Mar 13, 2018
Disposition
Mar 09
Form 4
$3.30
$6.00M
Feb 22, 2018
10.88M
Options
Feb 20
Form 3
Feb 01, 2017
9.06M
Showing 3 results

MULESOFT, INC

Investor
Updated May 09, 2018
Form 4
-100.00%
-16.12M
May 09, 2018
Options
May 01
Form 4
Mar 22, 2017
16.12M
Options
Mar 22
Form 3
Mar 16, 2017
320.78K
Showing 3 results

Robinhood Markets, Inc.

Investor
Updated May 04, 2022
Form 4
-50.00%
-23.82M
$10.06
-$19.64K
May 04, 2022
23.82M
Sale
May 02 - May 03
Form 4
-33.37%
-23.87M
$14.22
-$29.60K
Feb 01, 2022
47.65M
Sale
Jan 28 - Jan 31
Form 4
-1.96%
-1.43M
Nov 12, 2021
71.51M
Disposition
Nov 10
Form 4
-1.92%
-1.43M
Oct 29, 2021
72.94M
Disposition
Oct 27
Form 4
$26.60
Aug 03, 2021
74.37M
Options
Aug 02
Form 3
Jul 29, 2021
2.51M
Showing 6 results

Nkarta, Inc.

Investor
Updated Jul 16, 2020
Form 4
29.82%
666.67K
$18.00
Jul 16, 2020
2.90M
Purchase
Jul 14
Form 3
Jul 09, 2020
Showing 2 results

NeueHealth, Inc.

Investor
Updated Apr 10, 2024
Form 4
742.37K
Apr 10, 2024
742.37K
Purchase
Apr 08
Form 4
11.85%
175.53K
Dec 21, 2023
1.66M
Purchase
Dec 19
Form 4
7.29%
100.61K
Nov 02, 2023
1.48M
Purchase
Oct 31
Form 4
66.67%
552.26K
Sep 19, 2023
1.38M
Purchase
Sep 15
Form 4
828.39K
Aug 15, 2023
828.40K
Purchase
Aug 11
Form 4
137.70K
$1,000.00
$137.70M
Oct 19, 2022
137.70K
Purchase
Oct 17
Form 4
200.00K
$1,000.00
$200.00M
Jan 05, 2022
200.00K
Purchase
Jan 03
Form 4
76.29%
78.95M
$18.00
Jun 30, 2021
182.44M
Purchase
Jun 28
Form 3
Jun 24, 2021
46.86M
Showing 9 results

Verona Pharma plc

Investor
Updated Jan 04, 2021
Form 3
Jan 04, 2021
40.87M
Showing 1 results

Monte Rosa Therapeutics, Inc.

Investor
Updated Jun 30, 2021
Form 4
-67.20%
-15.76M
$19.00
Jun 30, 2021
7.69M
Buy-Options
Jun 28
Form 3
Jun 23, 2021
Showing 2 results

AVEO PHARMACEUTICALS, INC.

Investor
Updated Oct 21, 2022
Form 4
-99.99%
-3.95M
Oct 21, 2022
354.00
Disposition
Oct 19
Form 4
56.59%
1.43M
$5.25
$7.50M
Jun 22, 2020
3.95M
Purchase
Jun 19
Form 4
41.61%
8.70M
$0.58
$5.00M
Apr 08, 2019
29.59M
Purchase
Apr 08
Form 4
2.45%
500.00K
$1.55
$774.44K
Dec 21, 2018
20.90M
Purchase
Dec 20 - Dec 21
Form 4
0.30%
61.20K
$1.98
$121.08K
Dec 12, 2018
20.40M
Purchase
Dec 11
Form 4
0.85%
170.40K
$1.99
$338.35K
Dec 10, 2018
20.33M
Purchase
Dec 06 - Dec 10
Form 4
0.48%
96.40K
$1.98
$190.89K
Nov 30, 2018
20.16M
Purchase
Nov 28 - Nov 30
Form 4
0.85%
170.00K
$1.98
$336.11K
Nov 21, 2018
20.07M
Purchase
Nov 20
Form 4
6.42%
1.20M
$1.86
$2.24M
Nov 19, 2018
19.90M
Purchase
Nov 15 - Nov 19
Form 4
3.68%
663.72K
$2.26
$1.50M
Aug 22, 2018
18.70M
Purchase
Aug 21
Form 4
1.41%
250.60K
$1.96
$491.74K
Jul 20, 2018
18.03M
Purchase
Jul 18 - Jul 19
Form 4
1.09%
192.43K
$2.10
$404.08K
Jun 28, 2018
17.78M
Purchase
Jun 27 - Jun 28
Form 4
0.00%
275.00
$2.15
$591.25
May 30, 2018
17.59M
Purchase
May 30
Form 4
1.36%
236.48K
$2.13
$503.42K
May 21, 2018
17.59M
Purchase
May 17 - May 21
Form 4
0.41%
70.87K
$2.13
$151.25K
May 10, 2018
17.35M
Purchase
May 08
Form 4
5.63%
920.98K
$2.30
$2.12M
Apr 10, 2018
17.28M
Purchase
Apr 06 - Apr 10
Form 4
57.90%
6.00M
$0.50
$3.00M
Mar 29, 2017
16.36M
Purchase
Mar 28
Form 3
May 17, 2016
10.36M
Showing 18 results

APPIAN CORP

Investor
Updated Feb 15, 2018
Form 4
-99.42%
-2.71M
Feb 15, 2018
15.82K
Options
Feb 13
Form 4
-17.29%
-569.62K
$19.49
-$11.10M
Nov 27, 2017
2.72M
Sale
Nov 27
Form 4
-46.13%
-2.82M
$19.49
-$54.97M
Nov 21, 2017
3.29M
Sale
Nov 20
Form 4
May 31, 2017
6.11M
Options
May 31
Form 3
May 24, 2017
Showing 5 results

Mirum Pharmaceuticals, Inc.

Investor
Updated Jun 15, 2023
Form 4
-47.50%
-1.99M
Jun 15, 2023
2.20M
Disposition
Jun 13
Form 4
-85.99%
-25.70M
$15.00
Jul 24, 2019
4.19M
Buy-Options
Jul 22
Form 3
Jul 17, 2019
Showing 3 results

Adaptimmune Therapeutics PLC

Investor
Updated Jan 28, 2020
Form 4
62.50%
7.50M
$0.67
$5.00M
Jan 28, 2020
102.48M
Purchase
Jan 24
Form 4
18.76%
15.00M
$1.67
$25.00M
Sep 10, 2018
94.98M
Purchase
Sep 07
Form 4
8.95%
6.57M
$1.92
$12.59M
Mar 28, 2018
79.98M
Purchase
Mar 26 - Mar 27
Form 4
1.76%
1.27M
$1.91
$2.42M
Mar 23, 2018
73.41M
Purchase
Mar 21 - Mar 23
Form 4
21.71%
12.87M
$0.70
$9.01M
Mar 28, 2017
72.14M
Purchase
Mar 27
Form 3
Jan 04, 2016
59.27M
Showing 6 results

Loxo Oncology, Inc.

Investor
Updated Aug 06, 2014
Form 4
14.81%
230.77K
$13.00
Aug 06, 2014
1.79M
Purchase
Aug 06
Form 3
Jul 31, 2014
Showing 2 results

GENOCEA BIOSCIENCES, INC.

Investor
Updated May 26, 2022
Form 4
-100.00%
-10.38M
$0.07
-$750.66K
May 26, 2022
Sale
May 24 - May 25
Form 4
87.22%
6.30M
$1.19
$7.50M
Jul 28, 2020
13.53M
Purchase
Jul 24
Form 4
65.40%
2.86M
$3.50
$10.00M
Jun 25, 2019
7.23M
Purchase
Jun 24
Form 4
49.74%
12.44M
$0.30
$5.00M
Feb 19, 2019
37.44M
Purchase
Feb 14
Form 3
Jan 23, 2018
25.00M
Showing 5 results

Metacrine, Inc.

Investor
Updated Dec 27, 2021
Form 4
-16.25%
-497.27K
$0.99
-$494.48K
Dec 27, 2021
2.56M
Sale
Dec 10 - Dec 22
Form 4
33.57%
769.23K
$13.00
Sep 22, 2020
3.06M
Purchase
Sep 18
Form 3
Sep 15, 2020
Showing 3 results

Inozyme Pharma, Inc.

Investor
Updated Jul 28, 2020
Form 4
11.43%
250.00K
$16.00
Jul 28, 2020
2.44M
Purchase
Jul 25 - Jul 28
Form 3
Jul 23, 2020
Showing 2 results

Millendo Therapeutics, Inc.

Investor
Updated Dec 11, 2018
Form 3
Dec 11, 2018
1.77M
Showing 1 results

Eargo, Inc.

Investor
Updated May 26, 2021
Form 4
-30.67%
-2.00M
May 26, 2021
4.52M
Disposition
May 24
Form 4
42.40%
1.94M
$18.00
Oct 22, 2020
6.52M
Purchase
Oct 20
Form 3
Oct 15, 2020
Showing 3 results

ARDELYX, INC.

Investor
Updated Dec 09, 2019
Form 4
12.98%
400.00K
$6.25
$2.50M
Dec 09, 2019
6.56M
Grant
Dec 09
Form 4
15.63%
833.33K
$4.00
$3.33M
May 30, 2018
6.16M
Grant
May 25
Form 4
40.15%
1.53M
$8.73
$13.33M
Jul 20, 2016
5.33M
Purchase
Jul 18
Form 4
35.67%
1.00M
$10.00
$10.00M
Jan 14, 2016
3.80M
Purchase
Jan 13
Form 3
Jun 09, 2015
2.80M
Showing 5 results

Savara Inc

Investor
Updated Jul 19, 2023
Form 4
1.38%
333.33K
$3.00
$1.00M
Jul 19, 2023
24.47M
Purchase
Jul 17
Form 3
Mar 16, 2021
24.14M
Showing 2 results

Trevi Therapeutics, Inc.

Investor
Updated Apr 13, 2022
Form 4
84.48%
6.58M
$1.90
$12.50M
Apr 13, 2022
14.37M
Purchase
Apr 11
Form 4
93.56%
5.56M
Oct 19, 2021
11.49M
Purchase
Oct 18
Form 4
-0.01%
-564.00
$2.66
-$0.24
Apr 13, 2020
5.94M
Sale
Apr 03
Form 4
-74.04%
-12.66M
$10.00
May 13, 2019
4.44M
Buy-Options
May 09
Form 3
May 07, 2019
Showing 5 results

Tracon Pharmaceuticals, Inc.

Investor
Updated Mar 27, 2018
Form 4
51.34%
1.42M
$1.42
$2.00M
Mar 27, 2018
4.17M
Purchase
Mar 27
Form 4
46.05%
869.57K
$5.75
$5.00M
Nov 29, 2016
2.76M
Purchase
Nov 29
Form 4
-64.86%
-3.48M
$10.00
Feb 05, 2015
1.89M
Buy-Options
Feb 04
Form 3
Jan 29, 2015
Showing 4 results

Annexon, Inc.

Investor
Updated Jul 23, 2020
Form 3
Jul 23, 2020
Showing 1 results

Akouos, Inc.

Investor
Updated Dec 02, 2022
Form 4
-100.00%
-4.29M
Dec 02, 2022
Disposition
Nov 30
Form 4
15.87%
588.24K
$17.00
Jul 01, 2020
4.29M
Purchase
Jun 30
Form 3
Jun 25, 2020
Showing 3 results

Black Diamond Therapeutics, Inc.

Investor
Updated Jan 29, 2020
Form 3
Jan 29, 2020
Showing 1 results

Arsanis, Inc.

Investor
Updated Nov 20, 2017
Form 3
Nov 20, 2017
2.00M
Showing 1 results

Cerecor Inc.

Investor
Updated Oct 20, 2015
Form 4
-96.43%
-16.04M
Oct 20, 2015
594.25K
Options
Oct 20
Form 3
Oct 14, 2015
Showing 2 results

Regulus Therapeutics Inc.

Investor
Updated Mar 16, 2021
Form 4
Mar 16, 2021
Form 4
482.18%
9.90M
$1.90
$5.00M
Dec 07, 2020
11.95M
Purchase
Dec 04
Form 4
9.91M
$3.40
$7.13M
Dec 26, 2019
15.92M
Purchase
Dec 24
Form 4
556.60%
5.10M
$3.28
$4.46M
May 09, 2019
6.01M
Purchase
May 07
Form 3
Jul 31, 2017
10.99M
Showing 5 results

ARCA biopharma, Inc.

Investor
Updated Feb 27, 2018
Form 4
-100.00%
-1.46M
$0.50
-$731.27K
Feb 27, 2018
Sale
Feb 26
Form 3
Jun 17, 2015
10.22M
Showing 2 results

Marker Therapeutics, Inc.

Investor
Updated Mar 18, 2021
Form 4
114.29%
5.71M
$1.75
$10.00M
Mar 18, 2021
10.71M
Purchase
Mar 16
Form 3
Oct 18, 2018
5.00M
Showing 2 results

Casper Sleep Inc.

Investor
Updated Jan 26, 2022
Form 4
-100.00%
-6.26M
$6.90
-$43.17M
Jan 26, 2022
Disposition
Jan 25
Form 4
92.67%
16.06K
Jun 14, 2021
6.26M
Grant
Jun 10
Form 4
17.33K
Mar 09, 2020
6.24M
Grant
Mar 05
Form 4
25.14%
1.25M
$12.00
$15.00M
Feb 12, 2020
6.22M
Purchase
Feb 10
Form 3
Feb 06, 2020
4.97M
Showing 5 results

Strongbridge Biopharma plc

Investor
Updated Jan 09, 2018
Form 3
Jan 09, 2018
4.14M
Showing 1 results

CVENT INC

Investor
Updated Jun 11, 2015
Form 4
$26.65
-$11.75K
Jun 11, 2015
Acq/Dis
Jun 10 - Jun 11
Form 4
-100.00%
-136.00
$28.00
-$10.86K
May 19, 2015
Sale
May 18 - May 19
Form 4
5.43%
7.00
$27.28
-$3.52K
Dec 04, 2014
136.00
Acquisition
Dec 02
Form 4
129.00
Nov 28, 2014
129.00
Acq/Dis
Nov 25
Form 4
121.00
$25.79
$3.12K
Sep 09, 2014
s
Sep 08
Form 4
121.00
Aug 18, 2014
121.00
Acq/Dis
Aug 14
Form 3
Aug 08, 2013
Showing 7 results

Achaogen Inc

Investor
Updated Jun 07, 2016
Form 3
Jun 07, 2016
4.72M
Showing 1 results

Care.com Inc

Investor
Updated Jan 23, 2014
Form 3
Jan 23, 2014
Showing 1 results

INTERLEUKIN GENETICS INC

Investor
Updated Aug 02, 2016
Form 4
114.00%
40.24M
$0.10
$2.00M
Aug 02, 2016
75.54M
Purchase
Jul 29
Form 4
257.55%
39.74M
$0.10
$1.99M
Dec 29, 2014
55.17M
Purchase
Dec 23
Form 3
May 23, 2013
15.43M
Showing 3 results

Korro Bio, Inc.

Investor
Updated Apr 24, 2024
Form 4
1.66%
17.86K
$56.00
$999.99K
Apr 24, 2024
1.09M
Purchase
Apr 22
Form 3
Nov 07, 2023
1.07M
Showing 2 results

MBX Biosciences, Inc.

Investor
Updated Sep 17, 2024
Form 4
-90.35%
-33.83M
$16.00
Sep 17, 2024
3.61M
Buy-Options
Sep 16
Form 3
Sep 12, 2024
Showing 2 results